
Deerfield secures more than $600M for its next biotech venture fund
Deerfield Management, a prolific backer of biotechnology companies, has raised more than $600 million to invest further in young companies working on drugs, medical devices and healthcare services. The third of its kind from Deerfield, the fund will …